Sam is attending this digital conference for partnering and investment.<\/strong><\/p>\n<\/div>\n<\/div>\n

The main programme for the\u00a0<\/span>14th Annual<\/span>\u00a0<\/span>ELSF<\/span>\u00a0<\/span>is spread throughout 2 days (<\/span>10th-11th of March<\/span>) and will include<\/span>\u00a0<\/span>BioCapital & Investment Day<\/span>\u00a0<\/span>and<\/span>\u00a0<\/span>Bio-Pharma<\/span>\u00a0<\/span>Partnering & Therapeutics Day.<\/span>\u00a0<\/span>The two days will feature more than 14 hours of high-level speeches, panel discussions and spotlight showcases by leading<\/span>\u00a0<\/span>industry corporates. In addition, there is a global company showcase of\u00a0<\/span>50+<\/span>\u00a0presentations by established public, private, emerging and seed companies, offering<\/span>\u00a0<\/span>innovative solutions and seeking investment and partnering opportunities. We anticipate<\/span>\u00a0<\/span>400+<\/span>\u00a0<\/span>delegates<\/span>\u00a0<\/span>will register for the forum from all Life Sciences sectors, with<\/span>\u00a0the target audience being corporate and financial investors\/partners, bankers and advisors.<\/span><\/p>\n

Sachs Associates is a long established international conference company with offices in Switzerland and the UK. It runs a limited number of high profile conferences in Europe and the USA which are focused on bio-pharma, medtech, and digital health. These conferences focus on licensing and investment opportunities and all provide presenting opportunities for companies and excellent meeting facilities for all delegates to network.<\/span><\/p>\n